サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1193133

パンクレリパーゼ市場：用途別、年齢別、流通チャネル別：世界の機会分析・産業予測、2021-2031年

Pancrelipase Market By Application, By Age, By Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日: | 発行: Allied Market Research | ページ情報: 英文 157 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
パンクレリパーゼ市場：用途別、年齢別、流通チャネル別：世界の機会分析・産業予測、2021-2031年
出版日: 2022年10月01日
発行: Allied Market Research
ページ情報: 英文 157 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

パンクレリパーゼの世界市場は、2021年に17億6041万米ドル、2031年には26億8739万米ドルに達し、2022年から2031年にかけてCAGR4.3％で成長すると予測されています。

パンクレリパーゼの製造には、精製ブタ膵臓リパーゼ、アミラーゼ、プロテアーゼ酵素が使用されます。嚢胞性線維症や膵炎など、膵臓が正常に機能しない疾患では、食物の消化を助けるためにパンクレリパーゼが利用されます。パンクレリパーゼに含まれるリパーゼ、プロテアーゼ、アミラーゼは、タンパク質、炭水化物、脂質の分解に必要です。

パンクレリパーゼ市場の成長を促進する主な要因は、慢性膵炎の有病率の増加、嚢胞性線維症や食習慣＆ライフスタイルの変化で、パンクレリパーゼ市場の成長に起因する要因であるされています。また、主に膵臓の機能不全が市場の主要なトレンドであり、予測期間中の成長を促進すると予想されています。慢性膵炎、または長期間続く膵炎は、一部の人に発生する可能性があります。成人の慢性膵炎患者や膵臓摘出手術を受けた患者は、プロトンポンプ阻害剤（PPI）と併用したパンクレリパーゼ製剤の服用により、食物の消化を促進することができます。膵炎の発生率の増加は、市場の成長を促進します。

消化器系疾患の有病率の上昇は、パンクレリパーゼ市場を駆動します。インスタンスのためにNCBI、バイオテクノロジー情報のための国立センターによると、消化器系疾患は、アメリカで毎年推定6000万から7000万人に影響を与えます。このように、世界中で消化器系疾患の有病率が高まっており、これがさらにパンクレリパーゼ医薬品の必要性を強調し、市場の成長を引き起こしているのです。

しかし、医薬品開発に伴う高いコストやブランド薬の特許が市場成長の妨げになることが予想されます。一方、消費者のニーズを満たす新興市場の成長機会は、投資家にとって大きな投資機会となることが予想されます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資ポケット
  • ポーターのファイブフォース分析
  • 主要企業のポジショニング
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • COVID-19 影響分析

第4章 パンクレリパーゼ市場：用途別

  • 概要
    • 市場規模および予測
  • 慢性膵炎
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • 嚢胞性線維症
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • その他
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別

第5章 パンクレリパーゼ市場：年齢別

  • 概要
    • 市場規模および予測
  • 子供
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • 成人・老年
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別

第6章 パンクレリパーゼ市場： 流通チャネル別

  • 概要
    • 市場規模および予測
  • 病院薬局
    • 主な市場動向、成長要因と機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • ドラッグストア・小売薬局
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別
  • オンライン薬局
    • 主な市場動向、成長要因、機会
    • 市場規模・予測：地域別
    • 市場シェア分析：国別

第7章 パンクレリパーゼ市場：地域別

  • 概要
    • 市場規模・予測
  • 北米
    • 主な動向と機会
    • 北米市場規模・予測：用途別
    • 北米市場規模・予測：年齢別
    • 北米市場規模・予測：流通チャネル別
    • 北米市場規模・予測：国別
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 主な動向と機会
    • 欧州の市場規模・予測：用途別
    • 欧州市場規模・予測：年齢別
    • 欧州市場規模・予測：流通チャネル別
    • 欧州市場規模・予測：国別
      • ドイツ
      • フランス
      • 英国
      • その他欧州地域
  • アジア太平洋地域
    • 主な動向と機会
    • アジア太平洋地域の市場規模・予測：用途別
    • アジア太平洋地域の市場規模・予測：年齢別
    • アジア太平洋地域の市場規模・予測：流通チャネル別
    • アジア太平洋地域の市場規模・予測：国別
      • 日本
      • 中国
      • インド
      • オーストラリア
      • その他アジア太平洋地域
  • LAMEA
    • 主な動向と機会
    • LAMEAの市場規模・予測：用途別
    • LAMEAの市場規模・予測：年齢別
    • LAMEAの市場規模・予測：流通チャネル別
    • LAMEAの市場規模・予測：国別
      • ラテンアメリカ
      • 中東・アフリカ

第8章 企業情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合のヒートマップ
  • 主な発展

第9章 企業プロファイル

  • Abbvie Inc
  • Digestive Care, Inc.
  • Nestle S.A
  • Organon Canada Inc.
  • Viatris Inc.
  • Vivus Llc
図表

LIST OF TABLES

  • TABLE 1. GLOBAL PANCRELIPASE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 2. PANCRELIPASE MARKET FOR CHRONIC PANCREATITIS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 3. PANCRELIPASE MARKET FOR CHRONIC PANCREATITIS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 4. PANCRELIPASE MARKET FOR CYSTIC FIBROSIS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 5. PANCRELIPASE MARKET FOR CYSTIC FIBROSIS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 6. PANCRELIPASE MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 7. PANCRELIPASE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 8. GLOBAL PANCRELIPASE MARKET, BY AGE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 9. PANCRELIPASE MARKET FOR CHILDREN, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. PANCRELIPASE MARKET FOR CHILDREN, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. PANCRELIPASE MARKET FOR ADULTS AND GERIATRICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. PANCRELIPASE MARKET FOR ADULTS AND GERIATRICS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. GLOBAL PANCRELIPASE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. PANCRELIPASE MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. PANCRELIPASE MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. PANCRELIPASE MARKET FOR DRUG STORE AND RETAIL PHARMACIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. PANCRELIPASE MARKET FOR DRUG STORE AND RETAIL PHARMACIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. PANCRELIPASE MARKET FOR ONLINE PHARMACIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. PANCRELIPASE MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. PANCRELIPASE MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. NORTH AMERICA PANCRELIPASE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. NORTH AMERICA PANCRELIPASE MARKET, BY AGE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. NORTH AMERICA PANCRELIPASE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. NORTH AMERICA PANCRELIPASE MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. U.S. PANCRELIPASE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. U.S. PANCRELIPASE MARKET, BY AGE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. U.S. PANCRELIPASE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. CANADA PANCRELIPASE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. CANADA PANCRELIPASE MARKET, BY AGE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. CANADA PANCRELIPASE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. MEXICO PANCRELIPASE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. MEXICO PANCRELIPASE MARKET, BY AGE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. MEXICO PANCRELIPASE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. EUROPE PANCRELIPASE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. EUROPE PANCRELIPASE MARKET, BY AGE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. EUROPE PANCRELIPASE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. EUROPE PANCRELIPASE MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. GERMANY PANCRELIPASE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. GERMANY PANCRELIPASE MARKET, BY AGE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. GERMANY PANCRELIPASE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. FRANCE PANCRELIPASE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. FRANCE PANCRELIPASE MARKET, BY AGE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. FRANCE PANCRELIPASE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. UK PANCRELIPASE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. UK PANCRELIPASE MARKET, BY AGE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. UK PANCRELIPASE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. REST OF EUROPE PANCRELIPASE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. REST OF EUROPE PANCRELIPASE MARKET, BY AGE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. REST OF EUROPE PANCRELIPASE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. ASIA-PACIFIC PANCRELIPASE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. ASIA-PACIFIC PANCRELIPASE MARKET, BY AGE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. ASIA-PACIFIC PANCRELIPASE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. ASIA-PACIFIC PANCRELIPASE MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. JAPAN PANCRELIPASE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. JAPAN PANCRELIPASE MARKET, BY AGE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. JAPAN PANCRELIPASE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. CHINA PANCRELIPASE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. CHINA PANCRELIPASE MARKET, BY AGE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. CHINA PANCRELIPASE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. INDIA PANCRELIPASE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. INDIA PANCRELIPASE MARKET, BY AGE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. INDIA PANCRELIPASE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. AUSTRALIA PANCRELIPASE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. AUSTRALIA PANCRELIPASE MARKET, BY AGE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. AUSTRALIA PANCRELIPASE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. REST OF ASIA-PACIFIC PANCRELIPASE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. REST OF ASIA-PACIFIC PANCRELIPASE MARKET, BY AGE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC PANCRELIPASE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. LAMEA PANCRELIPASE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. LAMEA PANCRELIPASE MARKET, BY AGE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. LAMEA PANCRELIPASE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. LAMEA PANCRELIPASE MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. LATIN AMERICA PANCRELIPASE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. LATIN AMERICA PANCRELIPASE MARKET, BY AGE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. LATIN AMERICA PANCRELIPASE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. MIDDLE EAST & AFRICA PANCRELIPASE MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. MIDDLE EAST & AFRICA PANCRELIPASE MARKET, BY AGE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. MIDDLE EAST & AFRICA PANCRELIPASE MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79.ABBVIE INC: COMPANY SNAPSHOT
  • TABLE 80.ABBVIE INC: OPERATING SEGMENTS
  • TABLE 81.ABBVIE INC: PRODUCT PORTFOLIO
  • TABLE 82.ABBVIE INC: NET SALES
  • TABLE 83.ABBVIE INC: KEY STRATERGIES
  • TABLE 84.DIGESTIVE CARE, INC.: COMPANY SNAPSHOT
  • TABLE 85.DIGESTIVE CARE, INC.: OPERATING SEGMENTS
  • TABLE 86.DIGESTIVE CARE, INC.: PRODUCT PORTFOLIO
  • TABLE 87.DIGESTIVE CARE, INC.: NET SALES
  • TABLE 88.DIGESTIVE CARE, INC.: KEY STRATERGIES
  • TABLE 89.NESTLE S.A: COMPANY SNAPSHOT
  • TABLE 90.NESTLE S.A: OPERATING SEGMENTS
  • TABLE 91.NESTLE S.A: PRODUCT PORTFOLIO
  • TABLE 92.NESTLE S.A: NET SALES
  • TABLE 93.NESTLE S.A: KEY STRATERGIES
  • TABLE 94.ORGANON CANADA INC.: COMPANY SNAPSHOT
  • TABLE 95.ORGANON CANADA INC.: OPERATING SEGMENTS
  • TABLE 96.ORGANON CANADA INC.: PRODUCT PORTFOLIO
  • TABLE 97.ORGANON CANADA INC.: NET SALES
  • TABLE 98.ORGANON CANADA INC.: KEY STRATERGIES
  • TABLE 99.VIATRIS INC.: COMPANY SNAPSHOT
  • TABLE 100.VIATRIS INC.: OPERATING SEGMENTS
  • TABLE 101.VIATRIS INC.: PRODUCT PORTFOLIO
  • TABLE 102.VIATRIS INC.: NET SALES
  • TABLE 103.VIATRIS INC.: KEY STRATERGIES
  • TABLE 104.VIVUS LLC: COMPANY SNAPSHOT
  • TABLE 105.VIVUS LLC: OPERATING SEGMENTS
  • TABLE 106.VIVUS LLC: PRODUCT PORTFOLIO
  • TABLE 107.VIVUS LLC: NET SALES
  • TABLE 108.VIVUS LLC: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.PANCRELIPASE MARKET SEGMENTATION
  • FIGURE 2.PANCRELIPASE MARKET,2021-2031
  • FIGURE 3.PANCRELIPASE MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.PANCRELIPASE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.PANCRELIPASE MARKET,BY APPLICATION,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF CHRONIC PANCREATITIS PANCRELIPASE MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF CYSTIC FIBROSIS PANCRELIPASE MARKET,2021-2031(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF OTHERS PANCRELIPASE MARKET,2021-2031(%)
  • FIGURE 16.PANCRELIPASE MARKET,BY AGE,2021(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF CHILDREN PANCRELIPASE MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF ADULTS AND GERIATRICS PANCRELIPASE MARKET,2021-2031(%)
  • FIGURE 19.PANCRELIPASE MARKET,BY DISTRIBUTION CHANNEL,2021(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF HOSPITAL PHARMACIES PANCRELIPASE MARKET,2021-2031(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF DRUG STORE AND RETAIL PHARMACIES PANCRELIPASE MARKET,2021-2031(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF ONLINE PHARMACIES PANCRELIPASE MARKET,2021-2031(%)
  • FIGURE 23.PANCRELIPASE MARKET BY REGION,2021
  • FIGURE 24.U.S. PANCRELIPASE MARKET,2021-2031($MILLION)
  • FIGURE 25.CANADA PANCRELIPASE MARKET,2021-2031($MILLION)
  • FIGURE 26.MEXICO PANCRELIPASE MARKET,2021-2031($MILLION)
  • FIGURE 27.GERMANY PANCRELIPASE MARKET,2021-2031($MILLION)
  • FIGURE 28.FRANCE PANCRELIPASE MARKET,2021-2031($MILLION)
  • FIGURE 29.UK PANCRELIPASE MARKET,2021-2031($MILLION)
  • FIGURE 30.REST OF EUROPE PANCRELIPASE MARKET,2021-2031($MILLION)
  • FIGURE 31.JAPAN PANCRELIPASE MARKET,2021-2031($MILLION)
  • FIGURE 32.CHINA PANCRELIPASE MARKET,2021-2031($MILLION)
  • FIGURE 33.INDIA PANCRELIPASE MARKET,2021-2031($MILLION)
  • FIGURE 34.AUSTRALIA PANCRELIPASE MARKET,2021-2031($MILLION)
  • FIGURE 35.REST OF ASIA-PACIFIC PANCRELIPASE MARKET,2021-2031($MILLION)
  • FIGURE 36.LATIN AMERICA PANCRELIPASE MARKET,2021-2031($MILLION)
  • FIGURE 37.MIDDLE EAST & AFRICA PANCRELIPASE MARKET,2021-2031($MILLION)
  • FIGURE 38. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 39. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 40. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 41.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 42.COMPETITIVE DASHBOARD
  • FIGURE 43.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 44.ABBVIE INC.: NET SALES ($MILLION)
  • FIGURE 45.DIGESTIVE CARE, INC..: NET SALES ($MILLION)
  • FIGURE 46.NESTLE S.A.: NET SALES ($MILLION)
  • FIGURE 47.ORGANON CANADA INC..: NET SALES ($MILLION)
  • FIGURE 48.VIATRIS INC..: NET SALES ($MILLION)
  • FIGURE 49.VIVUS LLC.: NET SALES ($MILLION)
目次
Product Code: A15450

The global pancrelipase market was valued at $1,760.41 million in 2021, and is estimated to reach $2,687.39 million by 2031, growing at a CAGR of 4.3% from 2022 to 2031.

Purified porcine pancreatic lipase, amylase, and protease enzymes are used to make pancrelipase. In diseases where the pancreas is not functioning properly, such as cystic fibrosis and pancreatitis, pancrelipase is utilized to aid in improving food digestion. The lipases, proteases, and amylases included in pancrelipase are necessary for the breakdown of proteins, carbohydrates, and lipids.

The major factors that drive the growth of the pancrelipase market is increase in the increase in prevalence of chronic pancreatitis, cystic fibrosis and changing dietary habits &lifestyle, are the factors attributed to the growth of the pancrelipase market. In addition, primarily pancreatic insufficiency is a key trend of the market which is expected to fuel the growth in the forecast period.The pancreas is inflamed by pancreatitis. Chronic pancreatitis, or pancreatitis that lasts for a long time, can occur in some persons. Adults with chronic pancreatitis or those who have undergone pancreas removal surgery can enhance their food digestion by taking pancrelipase pills coupled with a proton pump inhibitor (PPI). Increase in incidence of the pancreatitis drives the market growth. 

Rise in prevalence of the digestive diseases drives pancrelipase market. For an instance According to the NCBI, National Center for Biotechnology Information, gastrointestinal diseases affect an estimated 60 to 70 million people annually in America. Thus, there is a growing prevalence of the digestive diseases around the globe which further highlights the need for the pancrelipase drugs causing the market growth

However high cost associated with drug development, patents of the branded drugs are expected to hinder the growth of the market. Conversely, growth opportunities in emerging market to suffice the consumer demands is expected to provide a great opportunity for the investors to invest in the market.

The global pancrelipase market is segmented on the basis of application, age, distribution channel and region. On the basis of application, the market is categorized into chronic pancreatitis, cystic fibrosis and others. By age, it is segmented into children and adult & geriatric. By distribution channel, it is segmented into hospital pharmacies, drug store and retail pharmacies and online pharmacies. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and Latin America, the Middle East, and Africa (LAMEA).

The major players profiled in the report are Abbvie Inc, Digestive Care, Inc, Nestle S.A., Organon Canada Inc., Viatris Inc., and Vivus LLC.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pancrelipase market analysis from 2021 to 2031 to identify the prevailing pancrelipase market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the pancrelipase market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global pancrelipase market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Age

  • Children
  • Adults and Geriatrics

By Application

  • Chronic Pancreatitis
  • Cystic Fibrosis
  • Others

By Distribution Channel

  • Online Pharmacies
  • Hospital Pharmacies
  • Drug Store and Retail Pharmacies

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East Africa
  • Key Market Players
    • Abbvie Inc
    • Digestive Care, Inc.
    • Nestle S.A
    • Organon Canada Inc.
    • Viatris Inc.
    • Vivus Llc

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: PANCRELIPASE MARKET, BY APPLICATION

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Chronic Pancreatitis
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market share analysis by country
  • 4.3 Cystic Fibrosis
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market share analysis by country
  • 4.4 Others
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market share analysis by country

CHAPTER 5: PANCRELIPASE MARKET, BY AGE

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Children
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market share analysis by country
  • 5.3 Adults and Geriatrics
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market share analysis by country

CHAPTER 6: PANCRELIPASE MARKET, BY DISTRIBUTION CHANNEL

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospital Pharmacies
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market share analysis by country
  • 6.3 Drug Store and Retail Pharmacies
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market share analysis by country
  • 6.4 Online Pharmacies
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market share analysis by country

CHAPTER 7: PANCRELIPASE MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Application
    • 7.2.3 North America Market size and forecast, by Age
    • 7.2.4 North America Market size and forecast, by Distribution Channel
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Key market trends, growth factors and opportunities
      • 7.2.5.1.2 Market size and forecast, by Application
      • 7.2.5.1.3 Market size and forecast, by Age
      • 7.2.5.1.4 Market size and forecast, by Distribution Channel
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Key market trends, growth factors and opportunities
      • 7.2.5.2.2 Market size and forecast, by Application
      • 7.2.5.2.3 Market size and forecast, by Age
      • 7.2.5.2.4 Market size and forecast, by Distribution Channel
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Key market trends, growth factors and opportunities
      • 7.2.5.3.2 Market size and forecast, by Application
      • 7.2.5.3.3 Market size and forecast, by Age
      • 7.2.5.3.4 Market size and forecast, by Distribution Channel
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Application
    • 7.3.3 Europe Market size and forecast, by Age
    • 7.3.4 Europe Market size and forecast, by Distribution Channel
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Key market trends, growth factors and opportunities
      • 7.3.5.1.2 Market size and forecast, by Application
      • 7.3.5.1.3 Market size and forecast, by Age
      • 7.3.5.1.4 Market size and forecast, by Distribution Channel
      • 7.3.5.2 France
      • 7.3.5.2.1 Key market trends, growth factors and opportunities
      • 7.3.5.2.2 Market size and forecast, by Application
      • 7.3.5.2.3 Market size and forecast, by Age
      • 7.3.5.2.4 Market size and forecast, by Distribution Channel
      • 7.3.5.3 UK
      • 7.3.5.3.1 Key market trends, growth factors and opportunities
      • 7.3.5.3.2 Market size and forecast, by Application
      • 7.3.5.3.3 Market size and forecast, by Age
      • 7.3.5.3.4 Market size and forecast, by Distribution Channel
      • 7.3.5.4 Rest of Europe
      • 7.3.5.4.1 Key market trends, growth factors and opportunities
      • 7.3.5.4.2 Market size and forecast, by Application
      • 7.3.5.4.3 Market size and forecast, by Age
      • 7.3.5.4.4 Market size and forecast, by Distribution Channel
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Application
    • 7.4.3 Asia-Pacific Market size and forecast, by Age
    • 7.4.4 Asia-Pacific Market size and forecast, by Distribution Channel
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Key market trends, growth factors and opportunities
      • 7.4.5.1.2 Market size and forecast, by Application
      • 7.4.5.1.3 Market size and forecast, by Age
      • 7.4.5.1.4 Market size and forecast, by Distribution Channel
      • 7.4.5.2 China
      • 7.4.5.2.1 Key market trends, growth factors and opportunities
      • 7.4.5.2.2 Market size and forecast, by Application
      • 7.4.5.2.3 Market size and forecast, by Age
      • 7.4.5.2.4 Market size and forecast, by Distribution Channel
      • 7.4.5.3 India
      • 7.4.5.3.1 Key market trends, growth factors and opportunities
      • 7.4.5.3.2 Market size and forecast, by Application
      • 7.4.5.3.3 Market size and forecast, by Age
      • 7.4.5.3.4 Market size and forecast, by Distribution Channel
      • 7.4.5.4 Australia
      • 7.4.5.4.1 Key market trends, growth factors and opportunities
      • 7.4.5.4.2 Market size and forecast, by Application
      • 7.4.5.4.3 Market size and forecast, by Age
      • 7.4.5.4.4 Market size and forecast, by Distribution Channel
      • 7.4.5.5 Rest of Asia-Pacific
      • 7.4.5.5.1 Key market trends, growth factors and opportunities
      • 7.4.5.5.2 Market size and forecast, by Application
      • 7.4.5.5.3 Market size and forecast, by Age
      • 7.4.5.5.4 Market size and forecast, by Distribution Channel
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Application
    • 7.5.3 LAMEA Market size and forecast, by Age
    • 7.5.4 LAMEA Market size and forecast, by Distribution Channel
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Latin America
      • 7.5.5.1.1 Key market trends, growth factors and opportunities
      • 7.5.5.1.2 Market size and forecast, by Application
      • 7.5.5.1.3 Market size and forecast, by Age
      • 7.5.5.1.4 Market size and forecast, by Distribution Channel
      • 7.5.5.2 Middle East & Africa
      • 7.5.5.2.1 Key market trends, growth factors and opportunities
      • 7.5.5.2.2 Market size and forecast, by Application
      • 7.5.5.2.3 Market size and forecast, by Age
      • 7.5.5.2.4 Market size and forecast, by Distribution Channel

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Abbvie Inc
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Digestive Care, Inc.
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Nestle S.A
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Organon Canada Inc.
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Viatris Inc.
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Vivus Llc
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments